reading prior authorization threads from 2024 and half of it aged badly
reading prior authorization threads from 2024 and half of it aged badly, which sounds obvious until you try to state the evidence for it. Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.…
External review, which is the most underused mechanism discussed on this board.
Internal appeals are decided by the plan. External review sends the determination to an independent body. Where it applies its decision binds the plan, and the deadlines to request it are short and strictly enforced.
The two things that trip people up: not knowing it exists, and exhausting the internal levels so slowly that the external window closes. Ask on the first denial what the external route is and what the deadline will be. Availability and rules vary by jurisdiction and plan type, so say where you are when you ask here.
Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.
Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.
New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January.
Peer-to-peer took fifteen minutes and resolved something a written appeal had been sitting on for a month.
Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.
That criterion is from the previous plan year. The current bulletin has different wording.
the formulary is published, read it before you appeal
Has a peer-to-peer been offered or requested?
Small fix — external review is independent of the plan. The second-level internal appeal is not.